Treatment of patients with glomus jugulare tumours (GJT) and its subjective effect on quality of life (QoL) measures

Andrea L.O. Hebb, Niki Erjavec, David P. Morris, Nael M. Shoman, Liam Mulroy, Simon A. Walling

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)

Abstract

Cerebellopontine angle (CPA) tumours account for 6–10% of intracranial tumours. The most common CPA tumours are vestibular schwannomas (VS), also known as acoustic neuromas, benign tumours of the vestibulocochlear nerve. Less common but symptomatic skull base lesions are glomus jugulare tumours (GJT), of which approximately 40% are identified as CPA tumours. Initial symptoms for GJT may include hearing loss and tinnitus and progress to various cranial nerve dysfunctions. Three well-accepted treatment modalities for such tumours include surgical resection, radiotherapy and/or conservative management employing serial MR or CT imaging. Patients' quality of life may be impacted by different treatment methods, so treatment decisions should be client centered.

Original languageEnglish
Article number102559
JournalAmerican Journal of Otolaryngology - Head and Neck Medicine and Surgery
Volume41
Issue number6
DOIs
Publication statusPublished - Nov 1 2020
Externally publishedYes

Bibliographical note

Publisher Copyright:
© 2020

ASJC Scopus Subject Areas

  • Otorhinolaryngology

Fingerprint

Dive into the research topics of 'Treatment of patients with glomus jugulare tumours (GJT) and its subjective effect on quality of life (QoL) measures'. Together they form a unique fingerprint.

Cite this